Listen to The Lancet Oncology-logo

Listen to The Lancet Oncology

Medical >

The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
More Information

Location:

United States

Description:

The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

Language:

English


Episodes

Diffuse intrinsic pontine glioma

8/14/2018
More
Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.

Duration:00:22:08

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer

6/30/2018
More
Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer.

Duration:00:09:49

Gender and cancer immunotherapy efficacy

6/1/2018
More
Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy.

Duration:00:09:37

PROs in regulatory decision making

4/25/2018
More
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.

Duration:00:11:33

Vulvar field resection

3/29/2018
More
Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields.

Duration:00:13:53

Chromatin organisation and cancer prognosis

3/1/2018
More
Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer.

Duration:00:07:24

Trial design for brain metastases: The Lancet Oncology: Jan 2018

12/30/2017
More
Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.

Duration:00:11:11

Lung cancer screening: The Lancet Oncology: November 27, 2017

11/28/2017
More
John Field discusses a European position statement on lung cancer screening using low-dose CT.

Duration:00:10:29

Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017

11/1/2017
More
Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA.

Duration:00:10:45

Cancer in Peru: The Lancet Oncology

9/28/2017
More
Ben Anderson talks about cancer care and cancer trends in Peru.

Duration:00:19:09

Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017

9/2/2017
More
Ricky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver metastases from colorectal cancer.

Duration:00:04:16

Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017

7/26/2017
More
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.

Duration:00:08:01

Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017

6/29/2017
More
Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer.

Duration:00:07:34

EANO and palliative care: The Lancet Oncology: June 2, 2017

6/3/2017
More
Martin Taphoorn outlines the importance of palliative care for patients with gliomas.

Duration:00:08:57

Head and neck cancer Series: The Lancet Oncology: April 26, 2017

4/26/2017
More
Sandro Porceddu discusses the new Lancet Oncology Series on head and neck cancer.

Duration:00:17:04

F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017

3/30/2017
More
Michele Cavo discusses the International Myeloma Working Group’s recommendations on the use of F-FDG PET/CT for patients with multiple myeloma and other plasma cell dyscrasias.

Duration:00:05:57

Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

3/2/2017
More
Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.

Duration:00:18:17

Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017

2/2/2017
More
Javier Torres-Roca and Louis Harrison join us to discuss their work on genome modelling and its uses in calculating the appropriate radiation dosage.

Duration:00:15:46

Cancer survivorship in the USA: The Lancet Oncology: 30 December

12/30/2016
More
Ann Partridge talks about cancer survival in the USA.

Duration:00:11:22

Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016

11/5/2016
More
Rafael Rossell discusses RET inhibitors and non-small cell lung cancer.

Duration:00:13:15